CurrentRheuma
Get Weekly

Topic · page 7 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 241–280 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Arthritis Res Ther

    Expression of CD163 and major histocompatibility complex class I as diagnostic markers for idiopathic inflammatory myopathies

    Diagnostic or prognostic study

  2. Rheumatology (Oxford)

    Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical–serological–pathological classification

    Cohort study

  3. Arthritis Res Ther

    Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis

    Cohort study

  4. Semin Arthritis Rheum

    Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New Zealand

    Cohort study

  5. Rheumatology (Oxford)

    Tacrolimus personalized therapy based on CYP3A5 genotype in Chinese patients with idiopathic inflammatory myopathies

    Cohort study

  6. Arthritis Res Ther

    Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome

    Cohort study

  7. Ann Rheum Dis

    Characterised intron retention profiles in muscle tissue of idiopathic inflammatory myopathy subtypes

    Mechanistic study

  8. Clin Exp Rheumatol

    Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies

    Cross-sectional study

  9. Rheumatology (Oxford)

    Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis

    Cross-sectional study

  10. Semin Arthritis Rheum

    Janus kinase inhibition (JAKi) therapy in refractory anti-synthetase syndrome: A retrospective cohort study

    Cohort study

  11. Rheumatology (Oxford)

    Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease

    Cross-sectional study

  12. Semin Arthritis Rheum

    Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis

    Case-control study

  13. Rheumatology (Oxford)

    Comparison of rituximab efficacy in treatment-naïve and refractory inflammatory myopathies: experiences from a tertiary care centre

    Cohort study

  14. Semin Arthritis Rheum

    Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review

    Meta-analysis

  15. Rheumatology (Oxford)

    Anti-HMGCR myopathy: estimated five-fold higher incidence in Polynesian compared with European populations in Aotearoa/New Zealand

    Cohort study

  16. Rheumatology (Oxford)

    Extracorporeal membrane oxygenation for acute lung injury in idiopathic inflammatory myopathies—a potential lifesaving intervention

    Cohort study

  17. Semin Arthritis Rheum

    The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group

    Cohort study

  18. Ann Rheum Dis

    Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification

    Cohort study

  19. Clin Exp Rheumatol

    Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines

    Cohort study

  20. Clin Exp Rheumatol

    Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study

    Cohort study

  21. Rheumatology (Oxford)

    Combination of cytoplasmic and nuclear patterns on Hep-2 antinuclear antibody is useful as a screening test for anti-synthetase syndrome

    Cohort study

  22. RMD Open

    Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease

    Diagnostic or prognostic study

  23. Rheumatology (Oxford)

    Longitudinal study of patients with anti-SAE antibody-positive dermatomyositis: a multicenter cohort study in China

    Cohort study

  24. RMD Open

    Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease

    Cohort study

  25. Arthritis Res Ther

    Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies

    Cohort study

  26. Rheumatology (Oxford)

    Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies

    Case-control study

  27. Clin Exp Rheumatol

    The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study

    Cohort study

  28. Semin Arthritis Rheum

    Unique characteristics of anti-MDA-5 associated dermatomyositis in Southern California with a large Hispanic population

    Cohort study

  29. Clin Exp Rheumatol

    Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies

    Cross-sectional study

  30. Clin Exp Rheumatol

    Cancer-associated myositis before and after the COVID-19 pandemic onset: a changing trend

    Cohort study

  31. Clin Exp Rheumatol

    Subclinical myocardial involvement in a cohort of patients with antisynthetase syndrome

    Cross-sectional study

  32. Clin Exp Rheumatol

    Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients

    Cohort study

  33. Clin Exp Rheumatol

    Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort

    Cohort study

  34. Clin Exp Rheumatol

    Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis

    Cohort study

  35. Clin Exp Rheumatol

    Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Diagnostic or prognostic study

  36. Rheumatology (Oxford)

    Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort

    Diagnostic or prognostic study

  37. Arthritis Rheumatol

    Myositis‐Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality

    Cross-sectional study

  38. Rheumatology (Oxford)

    A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses

    Cohort study

  39. Rheumatology (Oxford)

    Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

    Cross-sectional study

  40. Rheumatology (Oxford)

    Magnetic resonance imaging patterns revealing muscle pathology and clinical features in idiopathic inflammatory myopathies

    Cross-sectional study

All 430 Briefs in ExploreShowing Briefs 241–280 of 430, newest first